• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Altamira Therapeutics Ltd (NQ: CYTO )

    1.340 -0.060 (-4.29%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 63,289
    Open 1.340
    Bid (Size) 1.350 (2)
    Ask (Size) 1.380 (18)
    Prev. Close 1.400
    Today's Range 1.300 - 1.400
    52wk Range 1.050 - 17.20
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    Altamira Therapeutics Provides Business Update
    From Altamira Therapeutics Ltd
    Via GlobeNewswire

    Performance

    YTD
    -61.27%
    -61.27%
    1 Month
    +8.06%
    +8.06%
    3 Month
    -9.46%
    -9.46%
    6 Month
    -45.53%
    -45.53%
    1 Year
    -81.64%
    -81.64%

    More News

    Read More
    Hunting For Gains In Penny Stocks
    Via Talk Markets
    Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
    From FN Media Group LLC
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    What's Going On With Altamira Therapeutics Stock?
    Via Benzinga
    Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    Earnings Scheduled For April 10, 2024
    Via Benzinga
    Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    Nasdaq Turns Higher; Akanda Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Crude Oil Moves Higher; US New Home Sales Fall In February
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Altamira Therapeutics Stock Is Racing Higher
    Via Benzinga
    US Stocks Down; Chicago Fed National Activity Index Rises In February
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
    From Altamira Therapeutics Ltd
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.